Paediatric Consumer Health in New Zealand

Paediatric Consumer Health in New Zealand

In 2024, retail volume performances in paediatric consumer health in New Zealand are expected to vary across categories, with decline for paediatric analgesics and paediatric dermatologicals, for instance, but growth for nappy (diaper) rash treatments and paediatric cough, cold and allergy remedies. Nevertheless, all categories are expected to see value growth, with overall paediatric consumer health set to see a similar retail current value growth rate to that witnessed in 2023, strongly influe...

Euromonitor International's Paediatric Consumer Health in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.